Suzuki, E <br/><br/>
Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Nov 2006 
 - 578-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0753-3322 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2006.07.089  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzamides--pharmacology<br/>Cells, Cultured<br/>Cyclohexanones--pharmacology<br/>Cytokines--biosynthesis<br/>Lipopolysaccharides--pharmacology<br/>Macrophage Activation--drug effects<br/>Mice<br/>NF-kappa B--antagonists & inhibitors<br/>Nitric Oxide--biosynthesis<br/>Nitric Oxide Synthase Type II--antagonists & inhibitors<br/>Phagocytosis--drug effects<br/>Toll-Like Receptor 4--physiology